Process Technologies

Process technology developments are at the heart of any efforts to increase the productivity and robustness of biopharmaceutical manufacturing

This Process Technologies Roadmap is intended to guide industry participants towards better technological solutions in their manufacturing plants mid to long term, thus enabling expanded patient access to safe and cost-effective biopharmaceutical medicine while maintaining the viability of an R&D-driven drug development.

This first edition of this roadmap places special emphasis on technologies that have the greatest probability of success for implementation in a manufacturing setting within a 10-year time horizon. The document focuses on the most common production scenarios in the industry, namely on 2,000L disposable and 10,000L (and larger) stainless steel (SS) bioreactor capacities for the commercial production of monoclonal antibodies (mAbs).

This is 1 of 8 roadmap documents, to download others click on the ‘First Edition Documents’ menu

Contact address

The Gridiron Building
One Pancras Square

Newsletter subscribe

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

© 2019 Biophorum Operations Group · All Rights Reserved

Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ

Company Number 06794795 · VAT Number GB298617544

Share This

Share this

Share this post with your colleagues.